Difference between revisions of "STBT5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
Line 16: Line 16:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
 +
!
 +
!
 +
!
 +
!
 +
!
 
|-
 
|-
−
|[[STBT5:Lipoma|Lipoma]]
+
|CHAPTER 2 (SOFT TISSUE TUMOURS)
−
|Disease
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|[[STBT5:Lipomatosis|Lipomatosis]]
 
−
|Disease
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[STBT5:Lipoma|Lipoma]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 49: Line 64:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[STBT5:Lipomatosis|Lipomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 60: Line 75:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Angiolipoma_|Angiolipoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 72: Line 84:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
+
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
 
|Disease
 
|Disease
 
|
 
|
Line 79: Line 91:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 94: Line 100:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
+
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 104: Line 110:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Hibernoma|Hibernoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angiolipoma_|Angiolipoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 115: Line 123:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 127: Line 132:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
+
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
 
|Disease
 
|Disease
 
|
 
|
Line 137: Line 142:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 148: Line 155:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 160: Line 164:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
+
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 170: Line 174:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Hibernoma|Hibernoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 181: Line 187:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 193: Line 196:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
+
|[[STBT5:Atypical_spindle_cell_/_pleomorphic_lipomatous_tumour|Atypical spindle cell / pleomorphic lipomatous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 203: Line 206:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 214: Line 219:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 226: Line 228:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Elastofibroma|Elastofibroma]]
+
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 236: Line 238:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 247: Line 251:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 259: Line 260:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
+
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 266: Line 267:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 281: Line 276:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
+
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 291: Line 286:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 302: Line 299:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 314: Line 308:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
+
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
 
|Disease
 
|Disease
 
|
 
|
Line 324: Line 318:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 335: Line 331:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 347: Line 340:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
+
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
 
|Disease
 
|Disease
 
|
 
|
Line 357: Line 350:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Elastofibroma|Elastofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 368: Line 363:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 380: Line 372:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
+
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
 
|Disease
 
|Disease
 
|
 
|
Line 390: Line 382:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 401: Line 395:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 413: Line 404:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
+
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 423: Line 414:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 434: Line 427:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 446: Line 436:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
+
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
 
|Disease
 
|Disease
 
|
 
|
Line 456: Line 446:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
−
|Disease
 
−
|Shashi Shetty and Reba Daniel (resident)
 
−
|2/21/2024
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Katherine Geiersbach
 
 
|
 
|
−
|Template added 2/21/2024
+
|
 +
|
 
|-
 
|-
−
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
+
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 478: Line 462:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 489: Line 475:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 501: Line 484:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
+
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 508: Line 491:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 523: Line 500:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
+
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
 
|Disease
 
|Disease
 
|
 
|
Line 533: Line 510:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 544: Line 523:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 556: Line 532:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
+
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 566: Line 542:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 577: Line 555:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 589: Line 564:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
+
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 596: Line 571:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 611: Line 580:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
+
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 621: Line 590:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 632: Line 603:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 644: Line 612:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
+
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 654: Line 622:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 665: Line 635:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 677: Line 644:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
+
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 687: Line 654:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 698: Line 667:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 710: Line 676:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
+
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
 
|Disease
 
|Disease
 
|
 
|
Line 717: Line 683:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 732: Line 692:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
+
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 +
|Shashi Shetty and Reba Daniel (resident)
 +
|2/21/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Katherine Geiersbach
 
|
 
|
 +
|Template added 2/21/2024
 
|
 
|
 
|
 
|
Line 743: Line 708:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
+
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 750: Line 715:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 765: Line 724:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiosarcoma|Angiosarcoma]]
+
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 776: Line 740:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Glomus_tumour|Glomus tumour]]
+
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 786: Line 750:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 797: Line 763:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 809: Line 772:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyoma|Leiomyoma]]
+
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 819: Line 782:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 830: Line 795:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 842: Line 804:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
+
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 853: Line 820:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
+
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 863: Line 830:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 874: Line 843:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 886: Line 852:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
+
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 896: Line 862:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 907: Line 875:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 919: Line 884:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
+
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 930: Line 900:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
+
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
 
|Disease
 
|Disease
 
|
 
|
Line 940: Line 910:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 951: Line 923:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Schwannoma|Schwannoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 963: Line 932:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Neurofibroma|Neurofibroma]]
+
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 973: Line 942:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Perineurioma|Perineurioma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 984: Line 955:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 996: Line 964:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
+
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 1,007: Line 980:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
+
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,017: Line 990:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,028: Line 1,003:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,040: Line 1,012:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
+
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,050: Line 1,022:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,061: Line 1,035:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,073: Line 1,044:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
+
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 1,084: Line 1,060:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
+
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,094: Line 1,070:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,105: Line 1,083:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,117: Line 1,092:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
+
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,127: Line 1,102:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,138: Line 1,115:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,150: Line 1,124:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
+
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,160: Line 1,134:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,171: Line 1,147:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,183: Line 1,156:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
+
|[[STBT5:Glomus_tumour|Glomus tumour]]
 
|Disease
 
|Disease
−
|James Solomon, MD, PhD
 
−
|2/20/2022
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Alanna Church
 
 
|
 
|
 
|
 
|
−
|-
+
|
−
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,205: Line 1,172:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
+
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,215: Line 1,182:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,226: Line 1,195:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,238: Line 1,204:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
+
|[[STBT5:Leiomyoma|Leiomyoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,248: Line 1,214:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,259: Line 1,227:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,271: Line 1,236:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:PEComa|PEComa]]
+
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,281: Line 1,246:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,292: Line 1,259:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,304: Line 1,268:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
+
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
 
|Disease
 
|Disease
−
|Sadeem Qdaisat
 
−
|10/1/23
 
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|Working with Eric McGinnis
 
 
|
 
|
−
|2021 template added
+
|
−
|-
+
|
−
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,326: Line 1,284:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
+
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,336: Line 1,294:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,347: Line 1,307:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,359: Line 1,316:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
+
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,366: Line 1,323:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,381: Line 1,332:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Enchondroma|Enchondroma]]
+
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,388: Line 1,339:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Osteochondroma|Osteochondroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,403: Line 1,348:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Chondroblastoma|Chondroblastoma]]
+
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,413: Line 1,358:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,424: Line 1,371:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,436: Line 1,380:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
+
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,446: Line 1,390:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,457: Line 1,403:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,469: Line 1,412:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
+
|[[STBT5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,479: Line 1,422:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Neurofibroma|Neurofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,490: Line 1,435:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,502: Line 1,444:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
+
|[[STBT5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,512: Line 1,454:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,523: Line 1,467:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,535: Line 1,476:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Osteoma|Osteoma]]
+
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,545: Line 1,486:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,556: Line 1,499:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,568: Line 1,508:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
+
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,578: Line 1,518:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,589: Line 1,531:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,601: Line 1,540:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
+
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,611: Line 1,550:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,622: Line 1,563:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,634: Line 1,572:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
+
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,641: Line 1,579:
 
|
 
|
 
|
 
|
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,656: Line 1,588:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
+
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,666: Line 1,598:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,677: Line 1,611:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,689: Line 1,620:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
+
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,699: Line 1,630:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,710: Line 1,643:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,722: Line 1,652:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
+
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,732: Line 1,662:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,743: Line 1,675:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,755: Line 1,684:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
+
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,765: Line 1,694:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,776: Line 1,707:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,788: Line 1,716:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
+
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,798: Line 1,726:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,809: Line 1,739:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,821: Line 1,748:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
+
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
 
|Disease
 
|Disease
 +
|James Solomon, MD, PhD
 +
|2/20/2022
 
|
 
|
 +
|PENDING
 +
|
 +
|Alanna Church
 
|
 
|
 
|
 
|
Line 1,832: Line 1,764:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
+
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,842: Line 1,774:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,853: Line 1,787:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,865: Line 1,796:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
+
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,875: Line 1,806:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Bone_metastases|Bone metastases]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,886: Line 1,819:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,898: Line 1,828:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
+
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,908: Line 1,838:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,919: Line 1,851:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,931: Line 1,860:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
+
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,941: Line 1,870:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:PEComa|PEComa]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 1,952: Line 1,883:
 
|
 
|
 
|
 
|
−
|-
 
−
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
−
|Disease
 
 
|
 
|
 
|
 
|
Line 1,964: Line 1,892:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
+
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 1,973: Line 1,901:
 
|
 
|
 
|
 
|
−
|
+
|
−
|-
+
|
−
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
+
|
−
|Disease
+
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 1,986: Line 1,924:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
+
|
−
|Disease
+
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 1,997: Line 1,940:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
+
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 +
|Sadeem Qdaisat
 +
|10/1/23
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|Working with Eric McGinnis
 
|
 
|
 +
|2021 template added
 
|
 
|
 
|
 
|
Line 2,008: Line 1,956:
 
|
 
|
 
|-
 
|-
−
|[[STBT5:Werner_syndrome|Werner syndrome]]
+
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
 
|Disease
 
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Enchondroma|Enchondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Osteochondroma|Osteochondroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Chondroblastoma|Chondroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Osteoma|Osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Osteosarcoma|Osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Bone_metastases|Bone metastases]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Enchondromatosis|Enchondromatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[STBT5:Werner_syndrome|Werner syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|

Revision as of 11:34, 23 February 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Atypical lipomatous tumour / well-differentiated liposarcoma Disease
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease
Elastofibroma Disease
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease
Solitary fibrous tumour Disease Shashi Shetty and Reba Daniel (resident) 2/21/2024 PENDING Katherine Geiersbach Template added 2/21/2024
Inflammatory myofibroblastic tumour Disease
Low-grade myofibroblastic sarcoma Disease
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease
Infantile fibrosarcoma Disease
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease
Giant cell tumour of soft tissue Disease
Synovial haemangioma Disease
Intramuscular angioma Disease
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease
Papillary intralymphatic angioendothelioma Disease
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease
Solitary circumscribed neuroma Disease
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease
Haemosiderotic fibrolipomatous tumour Disease
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 PENDING Alanna Church
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease
Clear cell sarcoma of soft tissue Disease
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease
Ewing sarcoma Disease Sadeem Qdaisat 10/1/23 PENDING Working with Eric McGinnis 2021 template added
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease
Sarcoma with BCOR genetic alterations Disease
Subungual exostosis Disease
Bizarre parosteal osteochondromatous proliferation Disease
Periosteal chondroma Disease
Enchondroma Disease
Osteochondroma Disease
Chondroblastoma Disease
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Osteosarcoma Disease
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease
Epithelioid haemangioma of bone Disease
Epithelioid haemangioendothelioma of bone Disease
Angiosarcoma of bone Disease
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease
Osteofibrous dysplasia Disease
Adamantinoma of long bones Disease
Simple bone cyst Disease
Fibrocartilaginous mesenchymoma Disease
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease
Leiomyosarcoma of bone Disease
Undifferentiated pleomorphic sarcoma Disease
Bone metastases Disease
Solitary plasmacytoma of bone Disease
Primary non-Hodgkin lymphoma of bone Disease
Langerhans cell histiocytosis Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Enchondromatosis Disease
Li-Fraumeni syndrome Disease
McCune-Albright syndrome Disease
Multiple osteochondromas Disease
Neurofibromatosis type 1 Disease
Rothmund-Thomson syndrome Disease
Werner syndrome Disease


Retrieved from "https://ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=14206"